Lung cancer, Secondary cancers, Small cell lung cancer
Open
Phase 3
This trial is comparing BNT327 and chemotherapy with atezolizumab and standard chemotherapy.
It is for people having their first treatment for small cell lung cancer that has spread within the chest or to other parts of the body. This is called extensive stage lung cancer. This means that the cancer has spread beyond a single area that can be treated with .
Recruitment start: 28 February 2025
Recruitment end: 30 June 2026
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Kevin Franks
BioNTech SE
Last reviewed: 07 Apr 2025
CRUK internal database number: 20019
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
